With a view to avoiding untoward side-effects like vomiting, giddiness and especially crystaluria, the writer tried in a few cases a new sulphadrug recently introduced by Ciba under the name Elkosin.
With a view to avoiding untoward side-effects like vomiting, giddiness and especially crystaluria, the writer tried in a few cases a new sulphadrug recently introduced by Ciba under the name Elkosin.
The manufacturers claim that this drug, which is chemically 6-p-aminobenzenesulphonamido-2, 4-dimethylpyrimidine, is far more soluble than other sulpha-derivatives, so that crystaluria is made impossible even after administration of highest therapeutic doses. 
